REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
bamlanivimab/etesevimab (LY-CoV555/LY-CoV016) - Eli Lilly
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://clinicaltrials.gov/ct2/show/NCT04790786
 
Jun 15, 2023
 
Prev Next